Zobrazeno 1 - 10
of 230
pro vyhledávání: '"C, Rancoule"'
Autor:
P. Moreno-Acosta, A. Vallard, S. Carrillo, O. Gamboa, A. Romero-Rojas, M. Molano, J. Acosta, D. Mayorga, C. Rancoule, M.A. Garcia, M. Cotes Mestre, N. Magné
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-9 (2017)
Abstract Background Clinical parameters and proteins have recently been suggested as possible causes of radiotherapy (RT) resistance in cervical carcinoma (CC). The objective of the present study was to validate prognostic biomarkers of radiation res
Externí odkaz:
https://doaj.org/article/59a7bc071e8f4fae921765e4494c6f34
Autor:
Elodie Guillaume, Sophie Espenel, Nicolas Magné, M. Baury, S. De Oliveira Duarte, S. Sotton, Amel Rehailia-Blanchard, Nicolas Vial, A. Vallard, C. Rancoule, M.Y. He, Jean-Baptiste Guy
Publikováno v:
Cancer/Radiothérapie. 23:395-400
Purpose Lung and some digestive tumours move during a respiratory cycle. Four-dimensional scanography (4D-CT) is commonly used in treatment planning to account for respiratory motion. Although many French radiotherapy centres are now equipped, there
Autor:
Sophie Espenel, Emilie Bernichon, Nicolas Magné, Jane-Chloé Trone, Benoîte Méry, Amel Rehalia-Blanchard, Yuan Ming He, C. Rancoule
Publikováno v:
La Presse Médicale. 48:756-766
Human oncogenic papillomaviruses (HPV) have an increasingly prominent role in the genesis of many cancers. The oncogenic mechanisms associated with HPV are now better known and make it possible to explain the etiopathogenesis of the association. HPV
Autor:
Sophie Espenel, M.Y. He, A. Nivet, C. Rancoule, Amel Rehailia-Blanchard, Nicolas Magné, A. Vallard, Cyrus Chargari
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2019, 23, pp.240-247. ⟨10.1016/j.canrad.2018.05.010⟩
Cancer Radiothérapie, Elsevier Masson, 2019, 23, pp.240-247. ⟨10.1016/j.canrad.2018.05.010⟩
The small intestine is an organ frequently exposed in abdominal and pelvic irradiations. Acute and late toxicity can sometimes be difficult to manage and can significantly affect the quality of life of patients. Currently there is no guideline on the
Autor:
E. Daguenet, M. Maison, F. Tinquaut, E.-A. Giroux, L. Bertoletti, J.-P. Suchaud, C. Rancoule, J.-B. Guy, N. Magné
Publikováno v:
Thrombosis Research. 213:S21
Autor:
C. Rancoule, Benoîte Méry, Alexis Vallard, Claire Bosacki, Elise Rowinski, Jean-Baptiste Guy, Nicolas Magné
Publikováno v:
Bulletin du Cancer. 105:S280-S285
Resume Le cancer du rein metastatique est de mauvais pronostic, notamment en raison de l’impact limite des strategies therapeutiques habituelles, dont la radiotherapie en particulier. Le cancer du rein est considere comme radioresistant et la radio
Autor:
Omar Jmour, C. Rancoule, Jean-Baptiste Guy, Alexis Vallard, Elodie Guillaume, Nicolas Vial, Nicolas Magné
Publikováno v:
Bulletin du Cancer. 105:S92-S100
Resume Il est maintenant connu et reconnu que le systeme immunitaire a une place centrale dans les mecanismes d’oncogenese et de fait, dans l’efficacite des therapies anti-cancereuses. La mise en evidence du pouvoir immuno-stimulateur de la radio
Autor:
Jane-Chloé Trone, Amel Rehailia-Blanchard, Emilie Bernichon, Sophie Espenel, C. Rancoule, Nicolas Magné, Alexis Vallard, Ming Yuan He, Elodie Guillaume
Publikováno v:
Critical Reviews in Oncology/Hematology. 131:96-101
Triple-negative breast cancer (TNBC) (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is viewed as an aggressive subgroup of breast cancer. Treating patients with TNBC remains clinically challenging. It's now well estab
Autor:
Nicolas Magné, Sophie Espenel, A. Vallard, Jean-Baptiste Guy, Sylvie Sauvaigo, Claire Rodriguez-Lafrasse, C. Rancoule
Publikováno v:
Bulletin du Cancer. 104:962-970
Maintaining the genetic integrity is a key process in cell viability and is enabled by a wide network of repair pathways. When this system is defective, it generates genomic instability and results in an accumulation of chromosomal aberrations and mu
Publikováno v:
Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale. 134:160-164
Resume Objectifs Il existe peu de donnees concernant l’efficacite de la radiotherapie en modulation d’intensite volumetrique par arc therapie (VMAT), delivree dans le cadre du traitement des cancers epidermoides (CE) ORL. L’objectif etait d’e